JAMA[journal] 检索结果

61. The Oncology Care Model and Medicare Payments, Utilization, and Quality.

作者: Gabriel A Brooks.;Matthew Trombley.;Sean McClellan.;Qing Zheng.;Mary Beth Landrum.;Van Doren Hsu.;Colleen M Kummet.;Pang-Hsiang Liu.;Derek Hoodin.;Colin Doyle.;Carol Simon.;Nancy L Keating.
来源: JAMA. 2026年

The Oncology Care Model (OCM) was the Centers for Medicare & Medicaid Services' first cancer-focused alternative payment model, running from 2016 to 2022. The OCM aimed to reduce Medicare spending and improve quality of care for patients receiving chemotherapy.

62. Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

作者: Joseph Burns.;Stephen Daniels.;Justin P Zachariah.
来源: JAMA. 2026年

63. Rewriting the Narrative on the Oncology Care Model.

作者: Ravi B Parikh.;Stephen M Schleicher.;Samyukta Mullangi.
来源: JAMA. 2026年

64. National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C.

作者: Sanjay Kishore.;Margaret Hayden.;Micah Johnson.;Aaron S Kesselheim.;Benjamin N Rome.
来源: JAMA. 2026年

65. Embracing Bayesian Methods in Clinical Trials: FDA's Long-Awaited Draft Guidance.

作者: J Jack Lee.;Frank E Harrell.;Lisa M LaVange.;David J Spiegelhalter.
来源: JAMA. 2026年

66. FDA Draft Guidance for the Use of Bayesian Methods in Clinical Trials.

作者: Andrew Gelman.;Erik van Zwet.;Witold Wiecek.
来源: JAMA. 2026年

67. Sodium Bicarbonate Infusion for Severe Metabolic Acidemia and Acute Kidney Injury-Reply.

作者: Boris Jung.;Nicolas Molinari.;Samir Jaber.
来源: JAMA. 2026年

68. Sodium Bicarbonate Infusion for Severe Metabolic Acidemia and Acute Kidney Injury.

作者: Kanako Fukushima.;Masahiro Kashiura.;Takashi Moriya.
来源: JAMA. 2026年

69. Diagnosis and Management of Resistant Hypertension: A Review.

作者: Michel Azizi.;Wanpen Vongpatanasin.;Naomi D L Fisher.;Felix Mahfoud.;Laurence Amar.;Ajay J Kirtane.
来源: JAMA. 2026年

Hypertension, defined as office systolic blood pressure (SBP) 130 mm Hg or greater and/or diastolic blood pressure 80 mm Hg or greater, affects 43.9% of women and 49.5% of men in the US. Approximately 19.7% of patients treated for hypertension have apparent resistant hypertension (blood pressure ≥130/80 mm Hg) despite using 3 or more antihypertensive medications, preferably a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide-type diuretic, at maximally tolerated doses.

70. Opportunity for Improved Menopausal Hormone Therapy Prescribing.

作者: Deborah Bartz.;Ananya Tadikonda.;JoAnn E Manson.
来源: JAMA. 2026年

71. Management of Hypertension in Adults.

作者: Amber E Johnson.;Christopher D Jackson.;Jason T Alexander.
来源: JAMA. 2026年

72. Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards.

作者: Scott R Evans.;Thomas R Fleming.;Holly Janes.;Lori E Dodd.
来源: JAMA. 2026年

73. National Estimates of Pediatric Sepsis in US Hospitals Using Clinical Data.

作者: Chanu Rhee.;Fran Balamuth.;Kevin Dysart.;Evan Miller.;Zeyu Li.;Jing Huang.;Deepthi Gunturi.;Svetlana Ostapenko.;Robert Jin.;Laura DelloStritto.;Jeffrey Guy.;Russell Poland.;Kenneth Sands.;Tellen D Bennett.;Halden F Scott.;Elizabeth R Alpern.;L Nelson Sanchez-Pinto.;Seth Russell.;Peter E DeWitt.;Margaret N Rebull.;Charlotte Gray.;Latasha Daniels.;Seth Otto.;Camille Carter.;Lawrence J Cook.;Elena Tsemberis.;Jenna T Jordan.;Jack Kapes.;Robert Tunick.;Sameer S Kadri.;Brittany L Badesch.;Huai-Chun Chen.;Michael Klompas.;Scott L Weiss.
来源: JAMA. 2026年

Pediatric sepsis causes substantial morbidity and mortality, but population surveillance relies on administrative codes with limited and variable accuracy.